Latest filing published 08 Oct 2021 for Praxis Precision Medicines, Inc., €6.1M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
BSOF Parallel Master Fund L.P. is a declared insider of Praxis Precision Medicines, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 30 July 2021 to 6 October 2021, the count stands at 7 filings.
The open-market record consists of 7 sales worth €12.9M, with no purchase.
On 8 October 2021 came the latest disclosure, an open-market sale for €6.1M in Praxis Precision Medicines, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations